BD Evolve(TM) On-body Injector - Enabling variable drug delivery regimens
Products
Information
BD Evolve(TM) On-body Injector is being developed for pharmaceutical companies who seek flexible delivery options, as well as opportunities for improving the patient experience and lowering the cost of care. It supports delivery of biologics with customizable and programmable subcutaneous administration. BD Evolve(TM) On-body Injector is designed as a flexible system capable of continuous, episodic, or delayed delivery across a range of volumes, for extended wear and injection durations. It is meant to be programmable, with connected capabilities, and to enable subcutaneous administration of up to 3 mL of medication with up to 3 days of wear, allowing for medication delivery in a non-clinical setting. BD partners with you to develop self-injection systems that enable drug administration across a range of volumes and viscosities, leveraging BD primary container technology and expertise with a focus on reaching the market faster. https://drugdeliverysystems.bd.com/contact-us BD, the BD Logo and Evolve are trademarks of Becton, Dickinson and Company or its affiliates � 2021 BD. All rights reserved.
Main Categories
Pharmaceutical Packaging
All Categories
Connected drug delivery deviceDrug Delivery Devices & SystemsInjectable systems and componentsMedical Devices and Medical PackagingPharmaceutical PackagingPrimary PackagingSyringes/prefilled syringesWearable device
Distribution areas
OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
